Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely produced TPD tactics. With this review, we concentrate on the two preclinical experiments and scientific trials to offer an extensive summary of the protection and scientific performance of PROTACs and MGDs in hematologic malignancies ov